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Background: The FHIT tumor suppressor gene is arguably the most commonly altered gene in cancer since it is
inactivated in about 60% of human tumors. The Fhit protein is a member of the ubiquitous histidine triad proteins
which hydrolyze dinucleoside polyphosphates such as Ap3A. Despite the fact that Fhit functions as a tumor
suppressor, the pathway through which Fhit inhibits growth of cancer cells remains largely unknown.
Phosphorylation by Src tyrosine kinases provides a linkage between Fhit and growth factor signaling. Since many
G proteins can regulate cell proliferation through multiple signaling components including Src, we explored the
relationship between Gα subunits and Fhit.
Results: Several members of the Gαq subfamily (Gα16, Gα14, and Gαq) were found to co-immunoprecipitate with
Fhit in their GTP-bound active state in HEK293 cells. The binding of activated Gαq members to Fhit appeared to be
direct and was detectable in native DLD-1 colon carcinoma cells. The use of Gα16/z chimeras further enabled the
mapping of the Fhit-interacting domain to the α2-β4 region of Gα16. However, Gαq/Fhit did not affect either Ap3A
binding and hydrolysis by Fhit, or the ability of Gαq/16 to regulate downstream effectors including phospholipase
Cβ, Ras, ERK, STAT3, and IKK. Functional mutants of Fhit including the H96D, Y114F, L25W and L25W/I10W showed
comparable abilities to associate with Gαq. Despite the lack of functional regulation of Gq signaling by Fhit,
stimulation of Gq-coupled receptors in HEK293 and H1299 cells stably overexpressing Fhit led to reduced cell
proliferation, as opposed to an enhanced cell proliferation typically seen with parental cells.
Conclusions: Activated Gαq members interact with Fhit through their α2-β4 region which may result in
enhancement of the growth inhibitory effect of Fhit, thus providing a possible avenue for G protein-coupled
receptors to modulate tumor suppression.
Keywords: Fhit, G protein, Phospholipase Cβ, Src, Tumor suppressionBackground
The chromosomal localization of FHIT (Fragile Histidine
Triad) in the common fragile region of the human gen-
ome suggests a positive correlation between the loss or
inactivation of the FHIT gene and carcinogenesis. As
predicted for a tumor suppressor, the Fhit protein is
absent or markedly reduced in most human cancers [1].
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reproduction in any medium, provided the orexemplified by studies performed with FHIT-deficient
mice. Transgenic mice carrying one or two inactivated
Fhit alleles are viable and long-lived, but they show
increased rates of spontaneous and carcinogen-induced
cancers [2,3]. Encouragingly, the development of carcinogen-
induced tumors in these mice can be prevented by adminis-
tration of Fhit-expressing viral vectors [4]. Moreover,
Fhit overexpression enhances the susceptibility of many
types of cancer cells to exogenous inducers of apoptosis.
Fhit is one of the HIT (histidine triad) superfamily
members, which share an HxHxHxx motif (where x is a
hydrophobic residue) for nucleotide binding. Human
Fhit can hydrolyze dinucleoside polyphosphates, prefera-
bly Ap3A (to AMP and ADP). Despite numerous attempts
to elucidate the function of Fhit in tumor suppression, the. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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based on Fhit mutants with impaired substrate binding
(L25W and I10W/L25W mutants) or hydrolytic activity
(H96D mutant) supports the notion that the formation
and stability of the Fhit-Ap3A complex is crucial in growth
inhibition and apoptosis [5-7]. There is also evidence
to suggest that the intracellular concentration of Ap3A [8] or
its abundance relative to other dinucleoside polyphosphates
[9] may be correlated with Fhit-mediated apoptosis. The
hypothesis that the Fhit-Ap3A complex could be an import-
ant signaling molecule is an interesting possibility, but it has
yet to be confirmed biochemically.
A number of important cancer-related genes and path-
ways have recently been linked to Fhit. In colon cancer
cell lines, Fhit inhibits cell growth by attenuating the sig-
naling mediated by NFκB [10]. Fhit also inhibits the
activity of Akt, a key effector in the phosphatidylinositol
3-OH kinase (PI3K) pathway [11], and serves as a
physiological target of the Src tyrosine kinase [12]. Src is
a crucial cytoplasmic tyrosine kinase downstream of sev-
eral growth factor receptors, including those of the EGF
receptor family, which are often overexpressed and acti-
vated in human breast and ovarian carcinomas. Indeed,
activation of EGF receptor family members induces Fhit
degradation via the proteasome pathway which purport-
edly depends on Src-mediated Fhit phosphorylation at
Tyr114 [13]. However, biochemical data suggest that
phosphorylation favors the formation and persistence of
the Fhit-Ap3A complex [14]. Additionally, the mitochon-
drial Fhit can sensitize cells to apoptosis by binding and
stabilizing ferredoxin reductase [15], which is important
for the production of reactive oxygen species, and by en-
hancing mitochondrial Ca2+-uptake capacity [16]. These
reports help us to better understanding the mechanism
of tumor suppression by Fhit, but it remains unclear as
to how one can restore Fhit levels in the tumor cells for
cancer treatment.
Many signaling pathways operated by growth factors
are similarly modulated by the heterotrimeric G pro-
teins, which are critical players in many aspects of cellu-
lar function including cell proliferation, differentiation
and apoptosis. These signaling pathways include the
mitogen-activated protein kinases (MAPKs) [17], PI3K/
Akt [18], tyrosine kinases [19], and transcription factors
such as STAT3 and NFκB [20,21]. Gα subunits of
heterotrimeric G protein are classified into four subfam-
ilies (Gαs, Gαi, Gαq, and Gα12) [22]. It is noteworthy that
some Gα subunits can directly activate tyrosine kinases
such as Bruton's tyrosine kinase (Btk) [19]. Interestingly,
Src has also been shown to be activated by members
from all four subfamilies of G proteins [23-26] and this
may provide a link to regulate Fhit phosphorylation.
Constitutively activating mutations of the Gα subunits
that lock these signaling molecules in their GTP-boundactive state have been found to be associated with sev-
eral types of tumor [27]. Sustained stimulation of the Gq
and G12 pathways often leads to mitogenesis in various
cell types [28]. As a continuing effort to understand the
functions of G proteins in cell growth and proliferation,
we have explored the notion that G proteins can modu-
late Fhit. Surprisingly, we discovered that several α sub-
units of Gq family members can associate with Fhit only
in their active state.
Results
Constitutively active Gαq mutants stimulate Fhit
phosphorylation at Tyr114 through Src
Src is known to be activated by Gαq subunits [20,25]
and thus it is conceivable that stimulation of Gq-coupled
receptors may lead to Fhit phosphorylation. To facilitate
the detection of Fhit phosphorylation, we raised an anti-
phospho-Fhit Tyr114 antiserum which can detect Src-
induced Fhit Tyr114 phosphorylation with high sensitivity
(Figure 1A); overexpression of Src was sufficient to in-
duce Fhit phosphorylation in transfected HEK293 cells
due to the increase in activated Src (P-Src in Figure 1A).
We then began the study by examining the ability of the
Gq-coupled type 2 bradykinin receptor (BK2R) to stimu-
late Fhit phosphorylation by using a previously charac-
terized HEK293 cell line stably expressing BK2R (293/
BK2R cells) [29]. 293/BK2R cells transiently expressing
Flag-Fhit were stimulated with or without 100 nM
bradykinin for various durations and then assayed for
Fhit phosphorylation. Bradykinin-induced Fhit phos-
phorylation was hardly detected at short treatment times
(data not shown) but was reproducibly observed albeit
weakly with cells treated for 24 h (~2.5-fold of basal;
Figure 1B, DMSO control). As shown in Figure 1B,
bradykinin-induced Fhit Tyr114 phosphorylation was sig-
nificantly suppressed by pretreatment of the cells with
Src inhibitors (10 μM PP1 or 25 μM PP2). As HEK293
cells endogenously express the Gq-coupled muscarinic
M3 receptor [30], we examined whether receptor activa-
tion can induce Src-mediated Tyr114 phosphorylation of en-
dogenous Fhit. In contrast to 293/BK2R cells overexpressing
Flag-Fhit, we could not detect carbachol-induced phosphor-
ylation of endogenous Fhit in native HEK293 cells
unless the cells were treated with 100 μM Na3VO4, a
tyrosine phosphatase inhibitor (Figure 1C); this suggests
that phosphorylated Fhit may undergo dephosphorylation
and thereby making its detection extremely difficult when
the level of phospho-Fhit is limiting. Nevertheless, the
carbachol-induced phosphorylation of endogenous Fhit
was sensitive to Src inhibition by PP1 (Figure 1C). In order
to confirm that Gq signals can lead to Fhit phosphoryl-
ation, we made use of constitutively active mutants of Gαq
subunits as well as Fhit Y114F, a previously characterized
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Figure 1 Activation of Gαq stimulates Fhit Tyr
114 phosphorylation
in a Src-dependent mannar while activated Gαq can associate
with Fhit independent of Src. A, HEK293 cells were co-transfected with
either pcDNA3 (Vector) or pcDNA3-Fhit in combination with pcDNA3 or
pcDNA3-Src. Phosphorylated Src at Tyr416 and phosphorylated Fhit at
Tyr114 were determined by Western blotting. B, HEK293 cells stably
expressing type 2 bradykinin receptor were transiently transfected with
pFlag-CMV2-Fhit and then seeded onto 6-well plates. One day later, cells
were serum starved, pretreated with DMSO, 10 μM PP1 or 25 μM PP2 for
30 min and then treated with or without 100 nM bradykinin for 24 h.
The levels of phosphorylated Fhit were quantified relative to the controls
without bradykinin treatment (set as 1). * Significantly different from the
indicated controls (Dunnett t test, P < 0.05). C, Serum starved HEK293
cells were pretreated with 10 μM PP1 for 30 min and then treated with
or without 100 μM carbachol (CCH) in the absence or presence of 100
μM Na3VO4 for 24 h. * Carbachol treatment significantly increased the
phosphorylation of endogenous Fhit, while inhibition of Src significantly
suppressed this effect (Dunnett t test, n = 4, P < 0.05). D, HEK293 cells
were co-transfected with pFlag-CMV2-Fhit or pFlag-CMV2-Fhit Y114F in
combination with wild-type or constitutively active mutant of Gαq or
Gα14. The cDNA amount of Fhit for transfection was adjusted to achieve
comparable expression levels. E, HEK293 cells were co-transfected with
different combinations of pFLAG-CMV2-Fhit (F), pFLAG-CMV2 expression
vector (V), Gα16, Gα16QL, pcDNA3 (Vector) or Src constructs. After 24 h,
cells were collected and immunoprecipitated with anti-Flag affinity gel. *
The upper bands represent Src while the lower bands were heavy chains
of immunoglobulin G. Immunoblots shown represent one of three sets;
two other sets yielded similar results.
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arginine or glutamine (e.g., GαqR183C or GαqQ209L)
which abolishes the GTPase activity of the Gα subunit and
maintains them in the GTP-bound active state. Transient
co-expression of constitutively active Gαq mutants with
Fhit should lead to increased phosphorylation of wild-type
Fhit but not Fhit Y114F. Interestingly, co-expression of
constitutively active mutants of Gαq or Gα14 (another
member of the Gαq family) with Fhit resulted in increased
levels of the latter (Additional file 1), a phenomenon simi-
lar to that seen with bradykinin-treated 293/BK2R cells
(cf lanes 1 and 2 of the Flag-Fhit immunoblot in Figure 1B).
After adjusting the expression level of Fhit between
the various transfectants, Fhit phosphorylation was
clearly detected in cells co-expressing the constitutively
active GαqRC or Gα14QL (Figure 1D). Transfectants co-
expressing the wild-type Gα subunits exhibited little or no
Fhit phosphorylation while no phospho-Fhit could be
detected in cells co-expressing Fhit Y114F (Figure 1D).
As tyrosine kinases such as Btk can be directly acti-
vated by Gαq [19], we examined whether Src can form
complexes with Fhit and/or Gαq. Because activated Gα16
(GNA15, another member of Gαq subfamily with 85%
sequence identity to its mouse isoform Gα15 [31]) has
previously been shown to stimulate Src phosphorylation
at Tyr416 [21], we transfected HEK293 cell with different
combinations of Flag-Fhit, Src, Gα16 and Gα16QL and
then subjected the cell lysates to co-immonuprecipitation
assays using an anti-Flag affinity gel (Figure 1E). Both Src
and Gα16QL were detected in the immunoprecipitates of
Flag-Fhit when all three proteins were co-expressed simul-
taneously (Figure 1E, lane 4); note that the Src-specific
band (marked by an asterisk) ran just above a non-specific
IgG band. Control experiments omitting either Src or
Gα16QL demonstrated that both proteins were able to
interact with Flag-Fhit independently or endogenous
levels of interacting proteins (including Src and Gαq sub-
units) were not limiting (cf lanes 1 and 6 in Figure 1E).
Compared to Gα16QL, wild-type Gα16 exhibited a much
weaker ability to associate with Flag-Fhit (cf lanes 3 and 5
versus 4 and 6 in Figure 1E). Yet again, co-expression of
Gα16QL, but not wild-type Gα16 or Src, increased the
levels of Fhit in the transfectants (Figure 1E, lanes 4
and 6). Taken together, these results suggest that Fhit
may associate with Gα subunits in a GTP-bound state-
dependent and Src-independent manner.
Several Gαq members interact with Fhit in an
activity-dependent manner
The preceding experiments suggest that members of the
Gαq subfamily may interact with Fhit upon binding GTP.
To assess if this interaction is specific to Gαq subunits, we
performed co-immunoprecipitation assays using Flag-Fhit
and various Gα subunits. HEK293 cells were co-transfected
Figure 2 Fhit interacts with activated Gαq subunits but not with Gβ, small GTPases or RGS proteins. A, HEK293 cells were co-transfected
with either pFlag-CMV2-Fhit (F) or pFlag-CMV2 vector (V) and in combination with individual construct encoding wild-type or the constitutively active
mutant (RC for Gq, QL for the others) of different Gα proteins: Gq, G11, G14, G16, Gs, Gi2 and G13. After 24 h overexpression, cell lysates were prepared and
subjected to immunoprecipitation (IP) with anti-Flag agarose affinity gel. Total cell lysates (TCL) and the immunoprecipitates were analyzed by Western
blotting (WB). B, HEK293 cells were transfected with pcDNA3 (Vector) or pFlag-CMV2-Fhit together with Gα16 or Gα16QL. Transfectants were subjected to IP
with anti-Gα16 antiserum and protein G agarose. C, DLD-1 colon carcinoma cell lysates were incubated without or with GDPβS or GTPγS for 30 min at 4°C
and then subjected to IP with anti-Fhit antiserum and protein A agarose. D, HEK293 cells were co-transfected with either Flag-Gβ1 or pFlag-CMV2 vector
with HA-Gγ2 and pcDNA3-Fhit. Transfectants were immunoprecipitated with anti-Flag agarose affinity gel. E, HEK293 cells were co-transfected with either
pFlag-CMV2-Fhit or pFlag-CMV2 vector and in combination with individual HA-tagged construct encoding Ras, RGS19, Rap1A, or RGS16. Cell lysates were
immunoprecipitated with anti-Flag agarose affinity gel. Data shown represent one of three or more sets of immunoblots; other sets yielded similar results.
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Gα subunit in its wild-type or constitutively active form.
The expressions of Flag-Fhit and Gα subunits between dif-
ferent groups were adjusted to comparable levels prior to
co-immunoprecipitation with an anti-Flag affinity gel or
anti-Gα antiserum. Constitutively active mutants of Gαq,
Gα14, and Gα16, but not their wild-type counterparts,formed complexes with Flag-Fhit as predicted (Figure 2A).
However, despite being a member of the Gαq subfamily, the
constitutively active mutant of Gα11 failed to interact with
Flag-Fhit (Figure 2A). Representative members (Gαs, Gαi2
and Gα13) from each of the remaining Gα subfamilies were
also subjected to co-immunoprecipitation assays with
Flag-Fhit. As shown in Figure 2A, both wild-type and
Figure 3 Fhit interacts directly with activated Gα16. A, Purified GST-Fhit and His-Gα16 were analyzed by Coomassie blue staining. B, Equal
amounts (2 μg each) of purified GST or GST-Fhit was incubated with either GDPβS-bound or GTPγS-bound His-Gα16 at 4°C for 30 min. The
mixture was then subjected to GST pull-down assay with glutathione Sepharose beads. The input and GST pull down samples were analyzed by
Western blot.
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by Flag-Fhit, but not by the vector control, suggesting
that Gαs and Gα13 were capable of forming com-
plexes with Flag-Fhit irrespective of their activation
status. Neither wild-type nor constitutively active Gαi2
or Gαz was co-immunoprecipitated with Flag-Fhit, in-
dicating that both Gαi2 and Gαz behaved like Gα11
and could not associate with Fhit. To ascertain that
Fhit can truly interact with activated members of
Gαq, we examined the association between Gα16QL
and Fhit by reciprocal co-immunoprecipitation using an
anti-Gα16 antiserum to pull down Fhit from lysates of
HEK293 cells expressing wild-type Gα16 or Gα16QL; Fhit
was indeed co-immunoprecipitated along with Gα16QL,
but not with wild-type Gα16 (Figure 2B).
To further confirm their interaction in a native system,
we screened for cell lines that endogenously express Fhit
at a detectable level. Out of eight cell lines examined,
DLD-1 colon carcinoma cells have relatively high levels
of endogenous Fhit (data not shown) and they were used
to examine the interaction between endogenous Fhit and
Gαq. Cell lysates were incubated with non-hydrolysable
GDPβS or GTPγS (100 μM each at 4°C for 30 min)
to shift the endogenous G proteins to the basal or ac-
tivated state, respectively. Cell lysates were subsequently
subjected to co-immunoprecipitation with anti-Fhit anti-
serum and protein A sepharose. As compared to the con-
trols, more Gαq was detected in the Fhit immunoprecipitate
following GTPγS treatment (Figure 2C). This result
suggests that activated Gαq subunits can interact with
Fhit in a native cellular environment.
Since other signaling components along the G protein
pathway may also be involved in the Fhit/Gαq inter-
action, possible association of Fhit with Gβγ, regulators
of G protein signaling (RGS proteins), and monomericGTPases were examined by co-immunoprecipitation as-
says. Many effectors such as adenylyl cyclase and phospho-
lipase Cβ (PLCβ) can be simultaneously regulated by Gα
and Gβγ subunits. It is thus worth investigating whether
Fhit can also associate with Gβ1γ2, a Gβγ complex which is
known to bind various effectors including tyrosine kinases
[32]. We co-expressed Flag-tagged Gβ1 and HA-tagged
Gγ2 with untagged Fhit. The Flag-Gβ1 subunit was clearly
capable of forming a complex with HA-Gγ2, yet it was un-
able to co-immunoprecipitate Fhit (Figure 2D). As shown
in Figure 2E, both RGS19 (also known as Gα-interacting
protein, GAIP) and RGS16 did not co-immunoprecipitate
with Flag-Fhit. RGS4, RGS10, and RGS20 also failed to
interact with Fhit (data not shown). It should be noted
that, under identical experimental conditions, RGS19 and
Ras can interact efficiently with their known partners
[33,34]. Monomeric small GTPases contain the same
core domains for GTP-binding as the heterotrimeric
Gα subunits. Hence, the ability of Flag-Fhit to form a
complex with selected small GTPases was examined. Nei-
ther Ras nor Rap1A, which belong to the Ras family of the
small GTPase superfamily, could be co-
immunoprecipitated by Flag-Fhit (Figure 2E), suggesting
that small GTPases cannot form complexes with Fhit pro-
tein. These observations further support the notion that
Gαq/Fhit interactions are specific and not shared by other
signaling components along the G protein pathway.
Activated Gα16 interacts with Fhit directly through its
α2-β4 region
To investigate whether Fhit is able to directly interact
with activated Gαq members, we performed pull-down
assays using purified GST, GST-tagged Fhit (GST-Fhit)
and His-tagged Gα16 (His-Gα16). The purity of both
GST-Fhit and His-Gα16 proteins was estimated to be
Figure 4 The α2-β4 region is important for Gα16 to interact
with Fhit. A, Schematic representation of the N188, N210, N246,
N266, C128 and C164 chimeras. Predicted secondary structures are
illustrated as boxes (α helices) or ovals (β strands) above the
chimeras. Sequences from human Gαz are shaded in grey while
those from human Gα16 are in black. B, HEK293 cells were
transiently co-transfected with Flag tagged Fhit and the wild-type or
constitutively active mutants of Gα16, Gαz, N188, N210, N246, N266,
C128 or C164. Cell lysates were immunoprecipitated with anti-Flag
agarose affinity gel (upper panels). Expression levels of Gα16, Gαz,
Flag-Fhit and α-tubulin in the total cell lysate were detected by
western blotting (lower panels). Data shown represent one of three
or more sets of immunoblots; other sets yielded similar results. Figure 5 Interaction with Gαq is not dependent on the ability of
Fhit to bind or hydrolyze Ap3A. A, HEK293 cells were co-transfected
with either one of pFlag-CMV2 constructs encoding wild-type Fhit, Fhit-
Y114F, Fhit-L25W, Fhit-I10W/L25W, Fhit-H96D or pFlag-CMV2 vector and
in combination with wild-type Gαq or constitutively active Gαq mutant
(GαqRC). Cell lysates were immunoprecipitated with anti-Flag affinity gel.
Numerical values shown above the blot represent the relative intensities
of GαqRC being co-immunoprecipitated as compared to their
corresponding wild-type Gαq. The band intensity of wild-type Gαq pulled
down by Flag-Fhit was set as 1.0. Data shown represent one of three or
more sets of immunoblots; other sets yielded similar results. B, Ap3A (100
μM) was incubated in the absence (top) or presence of 1 μg GST protein
(middle) or 1 μg GST-Fhit protein (bottom) at 37°C for 10 min and then
subjected to HPLC analysis. The elution profiles were compared with
HPLC elution profiles of nucleotide standards (data not shown) including
Ap3A, AMP, ADP, GTPγS and GDPβS; their relative retention times are
marked above the reaction profile. C, Reaction profiles of Ap3A hydrolysis
by 0.5 μg GST-Fhit in the absence (top) or presence of 0.5 μg His-Gα16
which had been pre-incubated (30°C for 30 min) with 100 μM GDPβS
(middle) or 100 μM GTPγS (bottom). The amount of GST-Fhit was
reduced to 0.5 μg in order to facilitate the detection of possible
stimulatory effect of activated His-Gα16. GDPβS was detected as an extra
peak (middle) with a retention time of 28.5 min. D, Rate of Ap3A
hydrolysis was analyzed from the profiles shown in B and C; rate of
hydrolysis (%) was expressed as a percentage of Ap3A hydrolyzed during
the reaction, i.e. percentage difference between areas under the peaks of
Ap3A before and after the hydrolysis reaction.
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Equal amounts of recombinant His-Gα16 and GST-Fhit
(or GST) were incubated at 4°C for 30 min in the pres-
ence of 100 μM GDPβS or GTPγS in order to stabilize
His-Gα16 in the inactive or active conformation. Al-
though a small amount of His-Gα16 appeared to be non-
specifically associated with the glutathione sepharose
(Figure 3B, lanes 1 and 2 of right panel), GTPγS-His-
Gα16 was clearly pulled down by GST-Fhit (Figure 3B,
lane 4 of right panel). In contrast, GDPβS-His-Gα16
failed to associate with GST-Fhit. Collectively, these
results suggest that Fhit can selectively associate with ac-
tivated Gαq members except Gα11, and both purified
Gα16 and endogenous Gαq can interact with Fhit in their
active states. Such activation state-dependent interac-
tions are reminiscent of Gα/effector regulations.
In order to understand the molecular basis of the
interaction between Gαq and Fhit, we mapped the Fhit-
interacting regions on Gα16 by using a series of chimeras
in which discrete regions of Gα16 were swapped with
Gαz (a member of Gαi subfamily). These chimeras have
Figure 6 Fhit does not affect Gq-mediated PLCβ activation. A, HEK293 cells were co-transfected with wild-type or the constitutively active
mutant of Gα16 or Gαq in combination with pcDNA3 (Vector), Fhit and different Fhit mutants in the pcDNA3 vector: Fhit-Y114F (Y114F), Fhit-L25W
(L25W), Fhit-I10W/L25W (I10W/L25W) and Fhit-H96D (H96D). Transfectants were then labeled and lysed for determining the IP3 in cell lysates as
described in Methods. PLC activity was calculated as the amount of IP3 formed divided by the corresponding level of total inositol. B, HeLa cells
were transfected with control siRNA, Fhit siRNA or Fhit cDNA. One day later, expression levels of Fhit were detected by Western blot. C, Hela cells
in B were seeded into black-walled 96-well plates and the Ca2+ responses of these cells with histamine treatment (0.1, 1, or 10 μM) were detected by the
FLIPR device. Here shows the fluorescence signals of 0.1 μM histamine-induced Ca2+ response (FLU) in the control (dotted), Fhit-knocked down (dashed)
or Fhit-overexpressing (solid) HeLa cells. D, The maximal fluorescence signals of the Ca2+ responses (FLU) induced by 0.1, 1, or 10 μM histamine in the
control, Fhit-knocked down and Fhit-overexpressing HeLa cells were illustrated as white, gray and black, respectively.
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ceptor and effector interacting domains of Gα16 and Gαz
[35,36]. Gα16/z chimeras were preferred because of the
lack of endogenous expression of either Gα16 or Gαz in
HEK293 cells. The differential ability of Gα16QL and
GαzQL to interact with Fhit (Figure 2A) permits identifi-
cation of Fhit-interacting regions on Gα16 through gain
of function analyses. Since the effector interacting do-
main is likely to reside in the carboxyl half of the Gα
subunit [36,37], we have selected chimeras composed of
Gαz backbones with their C-terminal regions increas-
ingly replaced by Gα16 sequences all the way up to the
β2 domain (Figure 4A); mirror images of selected chi-
meras were also included. Among the various chimerasexamined, constitutively active N188QL and N210QL
(N-terminal 188 or 210 amino acids from Gαz, respect-
ively) were more efficiently pulled down by the anti-Flag
affinity gel than their corresponding wild-types; both
chimeras were as effective as, if not better than, Gα16QL
(Figure 4B). Constitutively active C128QL (C-terminal
128 amino acids from Gαz) also showed higher affinity
with Fhit than its wild-type (Figure 4B). In contrast,
N246QL, N266QL and C164QL failed to associate with
Flag-Fhit and behaved like the negative control GαzQL
(Figure 4B). These results demonstrate that the residues
between 210 and 246 of Gα16, which represent the re-
gions from α2 to β4, are required for interaction with
Fhit. Based on the structures of active Gαq in the
Figure 7 Fhit does not affect Gq-mediated TPR1 interaction or
Ras activation. A, HEK293 cells were co-transfected with different
combinations of pcDNA3 (Vector), Fhit, Gα16, Gα16QL, Flag-TPR1 and
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well as inactive Gαq with Gβγ complex [PDB: 3AH8],
molecular modeling of Gα16 predicted that the α2-β4
domain interacts with Gβγ in the inactive state but be-
comes exposed to the outer surface in the active state
(Additional file 2).
We have also attempted to determine the Gαq-interacting
region on Fhit by constructing a series of Fhit truncation
mutants with deletions at either the C- or N-terminus
(Additional file 3). However, deletion at either terminus
apparently impaired the stability of these mutants be-
cause their expressions were hardly detectable unless
the transfected cells were treated with the proteasome
inhibitor MG132 (Additional file 3). The inadequate
expression of these truncation mutants precluded co-
immunoprecipitation assays. Nevertheless, expressions
of two mutants were enhanced upon co-expression of
GαqQL, but not Gαq (Additional file 3). This suggests
that interaction with activated Gαq may stabilize Fhit.Flag tag constructs. One day later, cells were immunoprecipitated
with anti-Flag agarose affinity gel and probed for the presence of
Fhit, Gα16, and Flag-TPR1 in the immunoprecipitates using specific
antibodies as indicated. B, HEK293 cells were co-transfected with
either pcDNA3 (Vector) or Fhit in combination with pcDNA3, Gα16 or
Gα16QL, and subjected to Ras activation assay. The results shown on
the bar chart represent relative band intensities of Ras from RBD-Raf-1
immunoprecipitation normalized against their corresponding amounts
of total Ras (RBD-Raf-1/TCL). The value of vector-transfected basal
control was set as 100%. * Transfection of Gα16QL significantly induced
Ras activity as compared to vector control (Dunnett’s t test, P < 0.05).
Immunoblots shown represent one of three sets; two other sets
yielded similar results.Formation of the Gαq/Fhit complex is independent of
Fhit’s ability to bind Ap3A or be phosphorylated at Tyr
114
In an attempt to unveil the biological function of the
Gαq/Fhit interaction, we asked if such association is af-
fected by Fhit phosphorylation at Tyr114 or Fhit’s ability
to bind Ap3A. Previous studies have shown that Fhit
undergoes degradation upon phosphorylation by Src kin-
ase at Tyr114 [13] and activated Gαq can stimulate tyrosine
kinases [25]. Many signaling molecules regulate their
binding to protein partners through tyrosine phosphoryl-
ation. To test if this holds true for Fhit, we employed the
Fhit Y114F mutant in co-immunoprecipitation assays.
Since Flag-Fhit Y114F appeared to interact with constitu-
tively active GαqRC to an extent similar to Flag-Fhit
(Figure 5A), it suggests that phosphorylation of Fhit
Tyr114 is not a prerequisite for the formation of Gαq/Fhit
complexes.
Ap3A is the substrate of Fhit, and binding of Ap3A to
Fhit can affect the conformation of Fhit and hence its
ability to associate with other proteins. I10W/L25W and
L25W are Fhit mutants that exhibit 30- and 7-fold in-
crease of Km, respectively [7]. Apparently, these mutants
have a lower affinity to associate Ap3A although they
can still hydrolyze Ap3A. On the other hand, H96D, the
Ap3A hydrolytic dead mutant of Fhit does not hydrolyze
Ap3A and stabilizes the Ap3A/Fhit conformation [6].
Therefore, the associations between Gαq and these mu-
tants were assessed. As shown in Figure 5A, all three
mutants effectively co-immunoprecipitated GαqRC but
not wild-type Gαq; their interactions with GαqRC were
essentially similar to that observed with Flag-Fhit.
Hence, the binding of Ap3A to Fhit has little or no effect
on the formation of Gαq/Fhit complexes.Since many activated Gα subunits can regulate the en-
zymatic activity of their effectors, constitutively active
Gαq may modulate the hydrolase activity of Fhit. To test
this possibility, we used purified GST-Fhit and His-Gα16
proteins. The hydrolysis of Ap3A to AMP and ADP was
monitored by HPLC as described previously [38]. Upon
incubation with 1 μg GST-Fhit at 37°C for 10 min,
100 μM Ap3A was completely hydrolyzed to AMP and
ADP (Figure 5B). No hydrolysis was detected when
Ap3A was incubated with GST alone or with heat dena-
tured GST-Fhit (Figure 5B). We then optimized the
assay in order to cater for the detection of possible
stimulatory effect on the hydrolase activity of Fhit. Upon
reducing the amount of GST-Fhit in the reaction to
0.5 μg, approximately half of the Ap3A was hydrolyzed
to AMP and ADP (Figure 5C). To mimic the constitu-
tively active Gα16QL, the recombinant His-Gα16 protein
was loaded with 100 μM GTPγS. His-Gα16 protein
loaded with GDPβS was used as a negative control. As
shown in Figure 5C, the presence of GTPγS-bound or
GDPβS-bound His-Gα16 did not affect the ability of
GST-Fhit to hydrolyze Ap3A. The extent of Ap3A
Figure 8 Overexpression of Fhit does not affect constitutively
active Gαq or Gα16-induced phosphorylation of ERK, IKK, or
STAT3, or the activity of NFκB. A, HEK293 cells were co-transfected
with either pcDNA3 (Vector) or Fhit in combination with pcDNA3, Gαq or
GαqRC. Cell lysates were prepared and immunoblotted with anti-
phospho-ERK (P-ERK), anti-ERK (ERK), anti-phospho-IKK (P-IKK), or anti-IKK
(IKK). B, HEK293 cells were transfected as in A except the Gαq constructs
were replaced with those corresponding to Gα16. Cell lysates were
probed with anti-phospho-Tyr705-STAT3 (P(Y)-STAT3), anti-phospho
-Ser727-STAT3 (P(S)-STAT3) or anti-STAT3 (STAT3) antiserum. The vector
transfection control was set as 100% control. * The level of ERK, IKK and
STAT3 phosphorylation was significantly higher than the vector control
(Dunnett’s t test, p < 0.05). Immunoblots shown represent one of at least
three sets; all other sets yielded similar results. C, HEK293 cells stably
expressing the NFκB luciferase reporter gene, pNFκB-TA-luc, were co-
transfected with either pcDNA3 (Vector) or Fhit in combination with
pcDNA3, Gα16 or Gα16QL. One day later, transfectants were subjected to
luciferase assay. * Expression of Gα16QL significantly induced NFκB
stimulation as compared to pcDNA3 control (Dunnett’s t test, P < 0.05).
Figure 9 Stimulation of Gq-coupled receptors inhibits cell
growth in Fhit-expressing cells. A, 293/Fhit and 293/vector cells,
or H1299/Fhit and H1299/vector cells, which stably expressed Flag-
tagged Fhit and the Flag tag alone (vector), respectively, were
established as described in Methods. The expressions of Fhit were
confirmed by Western blot. B, 293/vector or 293/Fhit cells were
seeded into 96-well plates and 24 h later, the cells were treated with
or without 100 μM carbachol in the growth medium (Day 0). MTT
assay were performed on Day 0, 2, 4 and 6 to examine the relative
viable cell number. Absorbance values on Day 0 were set as 1 for
the respective group of cells. * Significantly different from that of
the 293/vector cells without carbachol treatment on the same day;
# carbachol treatment significantly inhibited the growth of 293/Fhit
cells; Dunnett’s t test, p < 0.05, n = 8. C, H1299/vector or H1299/Fhit
cells were seeded into 96-well plates and 24 h later, the cells were
treated with or without 100 nM bombesin (Day 0). MTT assays were
performed on Day 0 and 4. The values of MTT assay on Day 0 were set
as 1 for the respective group of cells. * Bombesin significantly increased
the growth of H1299/vector cells while it significantly inhibited the
growth of H1299/Fhit cells; Dunnett’s t test, p < 0.05, n = 8.
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three conditions (Figure 5D). Neither guanine nucleo-
tides interfered with the detection of the substrate or
product; GDPβS was eluted after Ap3A while GTPγS
could not be detected under our experimental condi-
tions. These results suggest that activated Gα16 does not
regulate the hydrolase activity of Fhit. However, it
remains possible that activated Gα16 can indirectly
modulate the enzymatic activity of Fhit in a cellular
environment.
Fhit does not alter the signaling function of Gαq
As members of the Gαq family are known to regulate
mitogenic pathways [39], Fhit may exert its tumor sup-
pressive effect by altering the functions of these Gαsubunits. To test this postulation, we determined the ef-
fect of Fhit on the ability of Gαq and Gα16 to regulate a
panel of known effectors. We first examined the ability
of GαqRC and Gα16QL to stimulate PLCβ in the absence
or presence of Fhit overexpression. HEK293 cells were co-
transfected with various combinations of Fhit, Fhit mu-
tants, and wild-type or constitutively active mutants of
Gαq and Gα16. As predicted, both GαqRC and Gα16QL
were capable of stimulating the endogenous PLCβ and in-
ducing the formation of IP3 (Figure 6A). Co-expression of
Fhit or its mutants neither stimulated nor inhibited the
ability of GαqRC and Gα16QL to activate PLCβ (Figure 6A).
We have also examined whether Fhit affects the ability of
endogenous Gq-coupled histamine receptors to stimulate
PLCβ activity in HeLa cells. As there are conflicting results
on the Fhit expression level in HeLa cells [16,40-43], we
have confirmed that the HeLa cells used in our study do
express endogenous Fhit to a level slightly higher than that
seen with HEK293 cells (Additional file 4), which are
known to express Fhit [8]. Variations in the reported Fhit
levels in HeLa cells might be attributed to differences in
the gene expression profiles of sublines. After knocking
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cells (Figure 6B), intracellular Ca2+ mobilization was mea-
sured by a FLIPR device with 0.1, 1 or 10 μM histamine as
agonist. Figure 6C showed typical Ca2+ signals induced by
0.1 μM histamine. There was no significant difference
among the maximal Ca2+ responses induced by different
concentrations of histamine in control, Fhit-deficient or
Fhit-overexpressing cells (Figure 6D). These observations
suggest that Fhit does not affect the Gαq/16/PLCβ pathway.
Apart from PLCβ, Gαq subunits are known to interact
with TPR1 which associates with activated Ras [34,44].
This raises the question whether Fhit could interfere
with Gα16QL/TPR1/Ras signaling. If Fhit and TPR1
compete for the same region on Gα16QL, Fhit will displace
and prevent TPR1 from binding to Gα16QL. In co-
immunoprecipitation assays, the ability of Flag-TPR1 to
pull down Gα16QL was not affected by the co-expression of
untagged-Fhit (Figure 7A, lane 2 versus lane 4), suggesting
that TPR1 and Fhit do not compete for the same region on
Gα16QL. Interestingly, Fhit was clearly present in the im-
munoprecipitates of lysates prepared from Flag-TPR1/Fhit/
Gα16QL transfectants (lane 4), whereas it was weakly
detected from those of Flag-TPR1/Fhit (lane 5) and Flag-
TPR1/Fhit/Gα16 (lane 3) transfectants. This might occur if
Gα16QL could simultaneously bind to both Fhit and Flag-
TPR1, thus forming a TPR1/Gα16QL/Fhit complex that can
be immunoprecipitated by the anti-Flag antibody. The pres-
ence of such a complex implies that Fhit may be involved
in regulating Gα16QL-mediated Ras activation. Ras activa-
tion assay was employed to investigate the effect of Fhit on
Gα16QL-induced Ras activity. In agreement with a previous
report [44], Gα16QL significantly induced Ras activation
as compared to the vector control and wild-type Gα16
(Figure 7B). However, there was no significant elevation or
attenuation of Ras activity when cells were co-transfected
with Fhit (Figure 7B).
In addition to PLCβ and Ras signaling, other cytoplas-
mic signaling molecules known to be regulated by Gαq
and Gα16 were examined in the presence or absence of
Fhit expression. Phosphorylation states of various signal-
ing molecules including ERK, STAT3 and IKK were
examined using phospho-specific antibodies. GαqRC
significantly stimulated the phosphorylations of ERK
and IKK and such responses were unaffected by the
presence of Fhit (Figure 8A). Similar results were obtained
with Gα16QL (data not shown). Likewise, Gα16QL signifi-
cantly stimulated STAT3 phosphorylation at both Tyr705
and Ser727 and these responses were not affected by the
co-expression of Fhit (Figure 8B); similar results were
obtained with GαqRC (data not shown).
Since phosphorylation of IKK results in activation of
NFκB transcription, Gα16QL-stimulated NFκB transcrip-
tional activity was also evaluated. As shown in Figure 8C,
Gα16QL significantly induced NFκB luciferase activity ascompared to pcDNA3 and Gα16 control. Consistent with
the phosphorylation profiles of IKK, expression of Fhit
did not affect the Gα16QL-stimulated NFκB transcrip-
tional activity.
Gq activation enhanced the growth inhibitory effect of
Fhit
As Fhit is a tumor suppressor, we asked whether the
growth inhibitory effect of Fhit could be affected upon
activation of Gq-coupled receptors. HEK293 and H1299
cells were chosen for this part of the study because they
endogenously express Gq-coupled muscarinic M1 and
gastrin-releasing peptide receptors (GRPRs), respectively.
We established 293/Fhit cells and H1299/Fhit cells
stably expressing Fhit (Figure 9A). Prolonged stimula-
tion of Gq-coupled receptors is often associated with
mitogenesis [28], and thus treatment of 293/vector
cells with 100 μM carbachol for 4 days or more sig-
nificantly stimulated cell growth (Figure 9B). In contrast,
carbachol significantly inhibited the growth of 293/Fhit
cells (Figure 9B); it should also be noted that 293/Fhit cells
exhibited reduced growth rate as compared to the 293/
vector cells (Figure 9B). A similar effect was observed in
H1299 cells. Bombesin has previously been shown to
stimulate the proliferation of non-small lung cancer cells
including H1299 cells [45,46]. In the present study,
activation of GRPR by 100 nM bombesin for 4 days
significantly increased the growth of H1299/vector
cells but it suppressed the growth of H1299/Fhit cells
(Figure 9C). These data suggest that mitogenic responses
elicited by Gq activation are re-directed into growth sup-
pressive signals when the level of Fhit is elevated. This
switching of functional outcome is consistent with the no-
tion that the tumor suppressive action of Fhit is correlated
to its expression level [47].
Discussion
Receptors coupled to members of the Gαq subfamily
mediate a wide range of diverse cellular responses, ran-
ging from cell growth and proliferation to cell differenti-
ation [39]. Established models indicate that the actions
of Gq-linked receptors are mediated by inositol lipid sig-
naling, but growing evidence suggests that these path-
ways alone cannot account for all of the responses.
Instead, the extensive list of diverse cellular events in-
volving Gαq-linked signals suggests that Gαq subfamily
members have multifaceted roles in signal transduction
which are not yet fully appreciated. The present study
has demonstrated that activated Gαq subunits can directly
interact with Fhit, a tumor suppressor widely implicated
in many types of cancer [1]. This is especially interesting
in view of the ability of Gαq subunits to modulate cell
















Figure 10 Distinct regulations of Fhit by Gq- and EGF-dependent
pathways. Agonist binding to Gq-coupled receptor leads to Gαq
activation and dissociation with Gβγ complex. Activated Gαq can
interact with Fhit and stabilize it, which results in increased Fhit level
and consequent enhancement of the growth suppressive effect of
Fhit. On the other hand, activation of the EGF receptor stimulates
Src-mediated phosphorylation of Fhit at the Tyr114 site. The
phosphorylated Fhit undergoes degradation which leads to a
decrease in the Fhit protein level as well as the tumor suppressive
effect of Fhit. Although activated Gαq also stimulates Src-mediated
Fhit Tyr114 phosphorylation, the overall Fhit protein amount is
increased rather than decreased, indicating that either an additional
signal is required for the induction of Fhit degradation (which is
concomitantly generated by EGF but not by activated Gαq; indicated
as a dashed line) or activated Gαq can up-regulate Fhit
via stabilization.
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a high degree of selectivity as demonstrated by the lack
of association of Fhit with Gβγ, monomeric GTPases,
and RGS proteins. Among the four subfamilies of Gα
subunits, at least three can interact with Fhit. Although
Gαi2 is often regarded as a representative member of the
Gi subfamily, its inability to interact with Fhit does not
necessarily indicate that the other eight Gαi members
cannot be partners of Fhit. Likewise, one cannot exclude
the possibility that some specific combinations of Gβγ
can interact with Fhit unless all viable permutations have
been tested. Since both the wild-type and constitutively
active mutants of Gαs and Gα13 associate with Fhit
equally well, such interactions may not be subjected to
dynamic cell signaling regulations. Far more interesting
is the activation state-dependent interaction between
Gαq subunits and Fhit. Activation of Gαq subunits by
agonist-bound receptor is expected to drive the forma-
tion of Gαq/Fhit complexes. Our data suggest that Fhit
can indeed interact with activated Gαq in a native cellu-
lar environment (Figure 2C) and it can directly associate
with activated Gα16 in vitro (Figure 3B). It is noteworthy
that the Gα subunits are attached to the inner leaflet of
the plasma membrane through fatty acylation and thus
Fhit needs to be present at the plasma membrane in order
to interact with Gα subunits productively. Analysis of Fhit
protein expression in subcellular fractions of normal rat
tissue suggests that it is localized at the plasma membrane
and the nucleus [49]. Hence Fhit can be in close proximity
to Gαq subunits for efficient interactions.
The inability of Gα11 to interact with Fhit is rather
surprising. The ubiquitously expressed Gα11 exhibits
90% sequence homology to Gαq and is thus more closely
related to Gαq than the primarily hematopoietic Gα14
and Gα16 [22], and yet the latter two could interact with
Fhit as effectively as Gαq. No report has indicated any
major difference between Gα11 and Gαq both in terms of
receptor coupling and effector regulation [39]. The abil-
ity of Fhit to distinguish Gα11 from Gαq as well as Gα14
and Gα16 thus represents a unique feature of Fhit, but
no immediate clue can be drawn as to why it does not
form a complex with Gα11.
The use of Gα16/z chimeras has enabled us to iden-
tify the α2-β4 region of Gα16 as an Fhit-interaction
domain (Figure 4). This region has been shown to
interact with Gβγ complex in the GDP bound Gαq but
it becomes available for effector interaction when Gαq
adopts the active GTP-bound conformation (Additional
file 2). In different Gαq members, this region associ-
ates with various effectors such as p63RhoGEF [50]
and PLCβ [51]. The binding of Fhit to the α2-β4 re-
gion may thus account for the preference of Fhit for
constitutively active Gαq mutants that are dissociated
from the Gβγ dimers.The interaction of Gα with Fhit opens a host of possi-
bilities in terms of their biochemical and cellular conse-
quences. Given the known functions of Gα subunits as
signal transducers and that only activated Gαq/14/16 can
interact with Fhit, perhaps the most logical prediction is
that Fhit acts as an effector of Gα. If this hypothesis is
correct, then activated Gα subunits may affect the
localization, stability, or function of Fhit. However, there
is a lack of effect of Gα16QL on the Ap3A hydrolase ac-
tivity of Fhit. Because Fhit binds and hydrolyzes Ap3A
in vitro [38], any model of Fhit function should take this
into account. The ability of GST-Fhit to hydrolyze Ap3A
into AMP and ADP was, however, unaffected by either
GDPβS- or GTPγS-bound His-Gα16. Moreover, Fhit mu-
tants with impaired affinity for Ap3A (L25W and I10W/
L25W) or a lack of hydrolase activity (H89D) formed
complexes with activated Gαq subunits as effectively as
wild-type Fhit (Figure 5A). These results suggest that
activated Gαq subunits have little effect, if any, on
the enzymatic activity of Fhit. However, it should be
noted that because the catalytic mechanism of Fhit
requires leaving-group exit and water entry at the
substrate-exposed surface of the dimeric enzyme,
polypeptides that bind to the Fhit-ApnA complex are
expected to stabilize the complex and retard turn-
over [6]. Subtle changes in the Km and/or Kcat of
Ap3A hydrolysis by Fhit will require detailed kinetic
studies.
Equally disappointing is that the formation of the Gαq/
Fhit complex was unable to interfere with any of the
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ical effector molecules of activated Gαq subunits are the
various isoforms of PLCβ. Despite the fact that PLCβ
also binds to the Fhit-interacting α2-β4 region of Gαq
[51], overexpression of wild-type Fhit or its mutants did
not affect GαqRC- or Gα16QL-induced PLCβ activity
(Figure 6A). Activated Gαq may have a higher affinity
and preference for PLCβ, resulting in the almost instant-
aneous formation of IP3 and mobilization of intracellular
Ca2+ (agonist-induced Ca2+ mobilization peaks within
10–15 s; Figure 6C). The co-localization of Gαq and
PLCβ in lipid rafts [52] helps to ensure the efficiency of
the Gq/PLCβ pathway. Fhit and other effectors may bind
to the activated Gαq when the latter becomes dissociated
from PLCβ. In this scenario, Fhit would not be able to
compromise PLCβ signaling effectively. However, it
should be noted that overexpression of p63RhoGEF can
inhibit Gα16QL-induced PLCβ activity albeit only par-
tially [53] and the presence of Fhit in lipid rafts remains
to be confirmed. Fhit can apparently associate with the
Gα16QL/TPR1 complex since it is detected in the
Gα16QL/TPR1 immunoprecipitates but not in the ab-
sence of Gα16QL (Figure 7A). The possible existence of
an Fhit/Gα16QL/TPR1 complex suggests that Fhit binds
to Gα16QL on a region distinct from that of TPR1, and
this is in agreement with our mapping of the Fhit-
interaction domain by using the Gα16/z chimeras (Figure 4)
and the fact that TPR1 interacts with the β3 domain of
Gα16 [36]. The lack of effect of Fhit on Gα16QL-induced
Ras activation further suggests that co-expression of Fhit
would not affect the activities of signaling molecules
downstream of Ras. This is indeed true for ERK, STAT3,
IKK, and NFκB (Figure 8).
Although the interaction of activated Gαq and Fhit is
independent of the ability of Fhit to become phosphory-
lated or to bind and hydrolyze Ap3A, activation of Gαq
could apparently increase Fhit Tyr114 phosphorylation
through Src (Figure 1B), stabilize Fhit (Figure 1B and
Additional file 1, Additional file 3) and enhance the cell
growth inhibition effect of Fhit (Figure 9). Gq signals
often lead to increased cell growth [28], but by forming
a complex with Fhit which can stabilize Fhit, activation
of Gαq may result in reduced cell growth (Figure 9).
Given that activation of EGF receptors triggers the deg-
radation of Fhit [13], and despite the demonstrated abil-
ity of activated Gαq to stimulate Fhit phosphorylation
(Figure 1B-C), it is rather puzzling to observe that acti-
vated Gαq can apparently increase the levels of Fhit
(Figure 1B and Additional file 1) and stabilize the trunca-
tion mutants of Fhit (Additional file 3). The divergent
regulatory outcome of phosphorylated Fhit may be attrib-
uted to the differing signaling capacities of EGF- and Gq-
dependent pathways, which could lead to conditional
proteasomal degradation of Fhit (Figure 10). Analternative explanation is that Fhit becomes less suscep-
tible to degradation upon binding activated Gαq, and this
might lead to an elevated level of Fhit (Figure 10). In-
creased Fhit levels can lead to the suppression of cell
proliferation (Figure 9B and C; [4]), while the knock
down of Fhit by siRNA increases the viability of
DLD-1 cells [10]. If activation of Gαq can elevate the
level of Fhit, this might account for the ability of Gq-
coupled receptors to inhibit cell proliferation (Figure 9B
and C; [48]). Further investigations are required to eluci-
date the mechanism by which activated Gαq regulates the
level of Fhit. We are currently pursuing the notion that
Gαq stimulates the translation of Fhit as we have prelimin-
ary data to suggest that the up-regulation of Fhit is
blocked by cycloheximide. Since the expression level of
Fhit may determine its functional outcome [47], it is tre-
mendously important that quantification of Fhit should be
carefully determined in any cellular system to be
employed. It should also be noted that Fhit expression can
enhance the effects of the p53 tumor suppressor [54] by
modulating p53-regulated genes [55]. Hence, the func-
tional relevance of Gαq/Fhit interaction should be
revisited in experimental systems with different p53
status.
Conclusions
The present study provides multiple indications that sev-
eral members of the Gαq family can bind to the tumor
suppressor Fhit in their GTP-bound active state. The
Fhit-interaction domain on the Gα subunit was identi-
fied as the α2-β4 region which would be occluded by the
Gβγ dimer in the GDP-bound inactive heterotrimeric Gq
protein, thus accounting for the preference of Fhit to
bind activated forms Gαq subunits. Neither the hydro-
lase activity of Fhit nor the signaling capacity of acti-
vated Gαq was affected by the formation of activated
Gαq/Fhit complexes. In cells with elevated levels of Fhit,
activation of Gq-coupled receptors led to growth sup-
pression rather than stimulation. Consistent with the
tumor suppressive function of Fhit, these observations




Human cDNAs of various Gα subunits were obtained
from Guthrie Research Institute (Sayre, PA). Wild-type
Fhit in pCMV-SPORT6 was purchased from Invitrogen
(Carlsbad, CA). pRcCMV-Fhit Y114F was a generous gift
from Dr. K. Huebner (Comprehensive Cancer Center
and Department of Molecular Virology, Immunology,
and Medical Genetics, Ohio State University). L25W,
I10W/L25W, and H96D mutants of Fhit were kindly pro-
vided by Dr. C. Brenner (Department of Genetics and
Zuo et al. Cell Communication and Signaling 2013, 11:59 Page 13 of 17
http://www.biosignaling.com/content/11/1/59Biochemistry, Dartmouth Medical School). Cell culture
reagents, including LipofectAMINE PLUS reagents were
purchased from Invitrogen (Carlsbad, CA).Anti-Gα16 and
anti-Gα14 were obtained from Gramsch Laboratories
(Schwabhausen, Germany). Anti-Fhit antibody was from
Invitrogen (Carlsbad, CA). Anti-Gq/11 α-subunit antibody
was purchased from Calbiochem (San Diego, CA). Anti-α-
tubulin antibody, anti-HA antibody, anti-Flag antibody
and anti-Flag affinity gel were from Sigma-Aldrich
(St. Louis, MO). Antisera against Gαs, Gαi2 and Gα13
were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA). Anti-GST antibody was from Abcam
(Cambridge, UK). Anti-phospho-Fhit-Tyr114 antibody was
raised in rabbits against a synthetic peptide corresponding
to AA 106–122 of human Fhit containing the phosphory-
lated tyrosine residue and an additional N-terminally
cysteine residue for coupling (C-DFHRNDSI(pY)EE
LQKHDK). Antibodies were affinity-purified using the
immunizing phospho-peptide coupled to SulfoLink®
Agarose beads from Thermo Scientific (Rockford, IL) and
subsequently cross-absorbed against the non-phosphorylated
peptide. Specificity of antibodies was verified by West-
ern blot using cell lysates prepared from HEK293
cells transiently transfected with cDNAs of Fhit or Fhit
and Src. Other antibodies were purchased from Cell
Signaling Technology (Danvers, MA). GDPβS and GTPγS
were from Calbiochem (San Diego, CA). Protein G-agarose
and dithiobis[succinimidylpropionate] (DSP) cross-linker
were from Pierce Biotechnology (Rockford, IL). ECL kit
and Glutathione SepharoseTM 4 Fast Flow beads were from
Amersham Biosciences (Piscataway, NJ). Ni-NTA Agarose
was obtained from Qiagen (Valencia, CA). Ras activation
kit was a product of Upstate-Millipore (Billerica, MA).
Construction of G protein chimeras and truncation
mutants of Fhit
The Gα chimeras (except C128) were constructed as de-
scribed previously [36] by PCR method using human
Gα16 and Gαz cDNAs. Briefly, the N-terminal 188, 210,
246 and 266 amino acids or the C-terminal 128 and 164
amino acids of Gα16 were swapped to the corresponding
regions of Gαz to generate N188, N210, N246, N266, C128
and C164. Primers were designed to cover the overlapping
regions of the chimeras, so that 5′ and 3′ fragments can be
annealed together to obtain the full length chimeras by
PCR. Then the full length PCR products were subcloned
into the pcDNA3 vector. All chimeras were confirmed
by dideoxynucleotide sequencing. Primer sequence for
constructing C128 is 5′- GTG CCT GGA GGA GAA
CAA CCA GAC AAG TCG GAT GGC AG-3′.
Flag-tagged Fhit truncation mutants, F131N, F95N,
F50C and F27C, were constructed by PCR method using
the human Fhit cDNA as a template. The primers were
designed based on the secondary structure of Fhit. Theouter forward and reverse primers of Fhit are 5′-CGA
AGC TTA TGG ACT ACA AAG ACG ATG ACG ACA
AGT CGT TCA GAT TTG GCC AAC ATC TC-3′ and
5′- CCT CGA GTC ACT GAA AGT AGA CCC GCA
GAG CTG C-3′, respectively. The reverse primers of
F131N and F95N are 5′-CCT CGA GTC ATG ATC
TCC AAG AGG CAG GAA AGT C-3′ and 5′-CCT
CGA GTC AAA CGT GCT TCA CAG TCT GTC CGG
C-3′, respectively. The forward primers of F50C and
F27C are 5′- CGA AGC TTA TGG ACT ACA AAG
ACG ATG ACG ACA AGC TGC GTC CTG ATG AAG
TGG CCG-3′ and 5′- CGA AGC TTA TGG ACT ACA
AAG ACG ATG ACG ACA AGA ATA GGA AAC CTG
TGG TAC CAG GAC-3′, respectively. All truncation mu-
tants were confirmed by dideoxynucleotide sequencing.Cell culture and co-immunoprecipitation
HEK293, DLD-1, HeLa and H1299 cells were obtained
from the American Type Culture Collection (CRL-1573,
Rockville, MD). They were maintained in Eagle’s mini-
mum essential medium (HEK293), RPMI-1640 medium
(DLD-1 and H1299) or ATCC-formulated Eagle’s mini-
mum essential medium (HeLa) at 5% CO2, 37°C with
10% fetal bovine serum, 50 units/mL penicillin and
50 μg/mL streptomycin.
For co-immunoprecipitation experiments, HEK293 cells
were grown to 80% confluency in 100 mm tissue culture
plates and then co-transfected with various combinations of
cDNAs (3 μg/plate) using 15 μL PLUS and LipofectAMINE
reagents in MEM. Serum was replenished 3 h after transfec-
tion. Cross-linking was performed one day after transfec-
tion; transfected HEK293 cells were washed with PBS twice
and then treated with 0.5 mM DSP in PBS for 10 min at
room temperature. Cells were then washed with PBS twice
and maintained in quenching solution containing 50 mM
glycine in PBS, pH 7.4, for 5 min. Cells were subsequently
lysed in ice-cold RIPA buffer (25 mM HEPES at pH 7.4,
0.1% SDS, 1% Nonidet P-40, 0.5% sodium deoxycholate,
1 mM dithiothreitol, 200 μM Na3VO4, 4 μg/mL aprotinin,
100 μM phenylmethylsulfonyl fluoride, and 2 μg/mL
leupeptin). Cell lysates were gently rocked with a pri-
mary antiserum at 4°C overnight, and then incubated
in 30 μL protein G-agarose (50% slurry) at 4°C for
2 h. Alternatively, the cell lysates were incubated in
30 μL anti-Flag affinity agarose gel (50% slurry) at 4°C
for 4 h. Immunoprecipitates were washed with ice-
cold RIPA buffer (400 μL) for four times, resuspended
in 50 μl RIPA buffer and 10 μl 6× sample buffer and
then boiled for 5 min. Target proteins in the immuno-
precipitates were analyzed by Western blots. Signal in-
tensities of the immunoreactive bands were quantified
using Image J software, version 1.38x (National Insti-
tutes of Health, USA).
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proteins, and GST pull-down
Fhit and Gα16 were subcloned into pGEX-4 T-1 and
pET21a(+) expression vectors, respectively, and
transformed into E. coli BL21 strain. 750 ml bacterial
cultures were grown at 37°C until the OD600 reached
0.6-0.8. The cultures were cooled down at 4°C for
20 min and 0.2 mM IPTG was added. The cultures were
then grown at 18°C overnight (for GST-Fhit) or 30°C for
15 h (for His-Gα16).
Cells were harvested by centrifugation for 15 min at
6,000 rpm and resuspended in 30 ml ice-cold lysis
buffer for GST-tagged Fhit (50 mM Tris, pH 7.5,
500 mM NaCl, 2 mM EDTA, 1 mM dithiothreitol, 1 mM
phenylmethylsufonyl fluoride, 2 μg/ml leupeptin) and
lysed by three rounds of sonication. After addition of
Triton X-100 to a final concentration of 1%, the lysate was
incubated at 4°C for 10 min. Cell debris was removed
by centrifugation at 18,000 rpm for 20 min. The
cleared supernatant was then incubated with Glutathi-
one Sepharose™ 4 Fast Flow beads at 4°C for 1.5 h with
gentle rotation. The beads were spun down at 4,000 rpm
for 1 min and washed four times with wash buffer (lysis
buffer with 150 mM NaCl and 10% glycerol). The beads
were then loaded into a chromatography column and
GST-Fhit was eluted washing buffer containing 20 mM
glutathione. Similar procedure was used for the purifica-
tion of His-tagged Gα16 except that Ni-NTA Agarose and
a different lysis buffer was employed (PBS, pH 8.0,
300 mM NaCl, 10 mM imidazole, 1 mM dithiothreitol,
1 mM phenylmethylsufonyl fluoride, 2 μg/ml leupeptin
and 20 mM 2-mercaptoethanol). His-Gα16 was eluted in
washing buffer containing a discontinuous gradient of
imidazole (from 30 mM to 250 mM). Proteins eluted at
fractions 6 and 7 were pulled. Purified GST or GST-Fhit
were mixed with Gα16 (2 μg each) in 500 μL pull-down
buffer (50 mM Tris–HCl, pH 7.5, 100 mM NaCl, 40 mM
NaP2O7 and 5 mM MgCl2) in combination with 1 μM
GDPβS or GTPγS, and then the mixture was incubated at
4°C for 30 min. Glutathione sepharose was then added
and the mixture was further incubated at 4°C for 2 h.
After being washed with pull-down buffer twice, the
beads were resuspended in sample buffer and subjected to
Western blot analysis.
Assay for diadenosine triphosphate hydrolysis by
recombinant Fhit
100 μM of Ap3A was incubated with or without recombin-
ant GST-Fhit protein or GST protein in 50 mM HEPES-
NaOH, pH 6.8, containing 0.5 mM MnCl2 for 10 min at
37°C in a total volume of 100 μl. Reactions were stopped
by heat inactivation (95°C, 10 min). 50 μl of nucleotide
standards and assay solutions were then analyzed by HPLC
with a Mono Q column, eluted with a gradient from 50 to600 mM ammonium bicarbonate, pH 8.5, at a flow rate of
1 ml/min. Absorbance of nucleotides were detected at
254 nm. For reactions that required His-Gα16 incubations,
0.5 μg His-Gα16 was pre-incubated with either GDPβS or
GTPγS (100 μM each) at 30°C for 30 min in GTP binding
activation buffer (50 mM Hepes, pH 8, 10 mM MgCl2,
1 mM dithiothreitol, 1 mM EDTA, and 100 mM NaCl)
prior to incubation with Fhit/Ap3A for 10 min. The extent
of Ap3A hydrolysis by 0.5 μg GST-Fhit was measured in
the absence or presence of His-Gα16, and was expressed as
percentage of Ap3A hydrolyzed during the reaction based
on the areas under the peaks of Ap3A before and after the
hydrolysis reaction [38].
Ras activation assay
HEK293 cells were co-transfected with 200 ng Gα, 200 ng
Flag-Fhit and 100 ng Ras cDNAs. After 1 day, transfec-
tants were serum starved for 4 h. Cells were then washed
twice with ice-cold PBS and lysed with the Mg2+lysis
buffer (MLB; 125 mM HEPES at pH 7.5, 750 mM NaCl,
5% Nonidet P-40, 50 mM MgCl2, 5 mM EDTA, 10% gly-
cerol, and appropriate protease inhibitors). Clarified cell
lysates were immunoprecipitated with 20 μL Raf-1 RBD
agarose for 45 min and subsequently washed three times
with 400 μL ice-cold MLB. Eluted protein samples in
50 μL MLB and 10 μL 6× sampling dye were then re-
solved in SDS gels and analyzed using specific anti-Ras
antibody.
Inositol phosphates accumulation assay
HEK293 cells were seeded on a 12-well plate at 2 × 105
cells/well one day prior to transfection. Various cDNAs at
a concentration of 0.5 μg/well were transiently transfected
into the cells using Lipofectamine PLUS® reagents. One
day after transfection, cells were labeled with inositol-free
Dubecco’s modified Eagle’s medium (DMEM; 750 μL)
containing 5% FBS and 2.5 μCi/mL myo-[3H]inositol over-
night. The labeled cells were then washed once with IP3
assay medium (20 mM HEPES, 5 mM LiCl, serum-free
DMEM) and then incubated with 500 μl IP3 assay
medium at 37°C for 1 h. Reactions were stopped by re-
placing the assay medium with 750 μL ice-cold 20 mM
formic acid and the lysates were kept in 4°C for 30 min
before the separation of [3H]inositol phosphates from
other labeled species by sequential ion-exchange chroma-
tography as described previously [56].
Transfection of HeLa cells with Fhit siRNA
Previously validated siRNA against Fhit (Fhit si1 se-
quence; [57]) was used for the knockdown of Fhit.
HeLa cells (1 × 106 cells) cultured in 10-cm plates were
transfected with siFhit (50 nM; Ribobio, Guangzhou,
China) or a negative universal control med GC siRNA
by LipofectamineTM RNAiMAX (Invitrogen, Carlsbad,
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seeded into 96-well plates for Ca2+ measurement or
5 × 105 cells per well into 6-well plates and lysed for
Western blotting.
Western blotting analysis
Protein samples were resolved on 12% SDS-polyacrylamide
gels and transferred to Osmonics nitrocellulose membrane.
Resolved proteins were detected by their specific primary
antibodies and horseradish peroxidase-conjugated second-
ary antisera. The immunoblots were visualized by chemilu-
minescence with the ECL kit from Amersham, and the
images detected in X-ray films were quantified by densito-
metric scanning using the Eagle Eye II still video system
(Stratagene, La Jolla, CA, USA).
Measurement of intracellular Ca2+ by FLIPR
The intracellular Ca2+ was measured by using an opti-
mized Fluorometric Imaging Plate Reader (FLIPR) proto-
col [58]. HeLa cells were seeded into clear-bottomed
black-walled 96-well plates. The growth medium was re-
placed by 200 μL labeling medium containing 1:1 (v/v)
ATCC-MEM medium: Hank’s balanced salt solution, 2.5%
(v/v) fetal calf serum, 20 mmol/L HEPES, pH 7.4,
2.5 mmol/L probenecid and 2 μmol/L Fluo-4 AM. Hista-
mine was prepared as a 5× solution in Hank’s balanced
salt solution into another polypropylene 96-well plate.
After 1 h labeling, cell and drug plates were placed in a
FLIPR (Molecular Devices, Sunnyvale, CA, USA). Imme-
diately after the addition of 50 μL of drug solution into
the cell medium, changes in fluorescence were monitored
over 120 s following excitation at a wavelength of 488 nm
and detection at 510–560 nm.
Luciferase assay
The growth medium of serum-starved transfectants
was removed and replaced by 25 μl of lysis buffer
provided in the Luciferase Reporter Gene Assay kit
(Roche Applied Science). The 96-well microplate was
shaken on ice for 30 min. The luciferase activity was de-
termined by a microplate luminometer LB96V (EG&G
Berthold, Germany). Injector M connected to lysis buffer
and injector P connected to the luciferin substrate were
set to inject 25 μl of each component into each well. A
1.6 sec delay time followed by a 2 sec measuring time
period was assigned to infector M whereas injector P was
measured for 10 s after introduction of luciferin into the
well. Results were collected by WinGlow version 1.24 and
expressed as relative luminescent units (RLU). Statistical
calculation was performed using KyPlot version 2.0.
Establishment of stable cell lines
HEK293 or H1299 cells stably expressing Flag-tagged
Fhit, or the pFlag-CMV2 vector were established byLipofectAMINE-mediated transfection along with ex-
cess pcDNA3 (9:1 ratio), followed by G418 selection
for 2 weeks. The resultant cell lines were named as
293/Fhit and 293/vector, or H1299/Fhit and H1299/
vector, respectively.
3-(4,5-dimethylthiazol-2-yl)-2,5-dephenyl-tetrazolium
bromide (MTT) colorimetric assay
Cells (5,000 cells/well of HEK293 or 2,000 cells/well of
H1299) were seeded in 96-well plates and incubated in
the absence or presence of agonists (100 μM carbachol
or 100 nM bombesin) for various durations. After re-
moving the growth medium, 100 μl MTT labeling re-
agent (0.5 mg/ml; Roche Applied Science) in serum-free
medium was added. The plate was incubated for 4 h at
37°C prior to the addition of 100 μl solubilization buffer
(10% SDS in 0.01 M HCl). The plate was incubated over-
night at 37°C. The absorbance reading was taken at the
wavelength of 570 nm, with the reference value taken at
the wavelength of 630 nm.
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